سعر ايناديلفوكس 500مجم /5 مل فيال 2025

Inadilvox 500 mg/5 mL vial (1 vial): levetiracetam concentrate for intravenous infusion after dilution, an antiepileptic, by Inad Pharma, Egypt.

• Treatment of partial-onset seizures.Population: Patients 1 month of age and olderDailyMed (U.S. National Library of Medicine)
• Adjunctive therapy for myoclonic seizures in juvenile myoclonic epilepsy.Population: Patients 12 years and olderDailyMed (U.S. National Library of Medicine)
• Adjunctive therapy for primary generalized tonic-clonic seizures in idiopathic generalized epilepsy.Population: Patients 6 years and olderDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions in adults: somnolence, asthenia, infection and dizziness; in pediatric patients: fatigue, aggression, nasal congestion, decreased appetite and irritability.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to levetiracetam; reactions have included anaphylaxis and angioedema.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Behavioral abnormalities and psychotic symptoms, including suicidal ideation, irritability and aggressive behavior; monitor for psychiatric signs.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Somnolence and fatigue; advise patients not to drive or operate machinery until they know how they are affected.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Serious dermatological reactions (SJS/TEN) and DRESS/multiorgan hypersensitivity; discontinue at the first sign of rash unless clearly not drug related.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Prolonged experience in pregnant women has not identified a drug-associated risk of major birth defects or miscarriage; developmental toxicity occurred in animals at doses similar to human doses; a pregnancy registry exists.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Levetiracetam is excreted in human milk; no data on effects on the breastfed infant; weigh benefits of breastfeeding against the mother's clinical need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Levetiracetam: Precise mechanism unknown; binds synaptic vesicle protein SV2A, which may contribute to its antiseizure effect (US label 12.1).